Medpace Holdings Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio25.4833.2826.8742.9034.17
Forward P/E27.3331.7427.3342.2331.38
P/S Ratio4.884.994.516.815.35
P/B Ratio12.4816.8317.058.176.14
Price/Tangible Book80.0031.2351.09
Price/FCF18.0023.7118.7633.1021.78
Price/OCF16.9221.7016.9829.5519.14
PEG Ratio1.521.521.521.521.52
Enterprise Value Ratios
EV/Revenue4.655.024.706.595.25
EV/EBITDA20.5826.0922.7734.2526.04
EV/EBIT21.9328.1324.6037.8929.08
EV/FCF17.1223.8819.5232.0221.37
Profitability & Returns
Return on Equity (ROE)0.58%0.60%0.37%0.21%0.19%
Return on Assets (ROA)0.15%0.14%0.12%0.08%0.08%
Return on Invested Capital (ROIC)0.97%0.54%0.40%0.28%0.22%
Return on Capital Employed (ROCE)0.45%0.46%0.51%0.18%0.18%
Leverage & Solvency Ratios
Debt/Equity0.180.290.540.150.16
Debt/EBITDA0.290.410.620.590.62
Debt/FCF0.260.410.590.630.58
Liquidity Ratios
Current Ratio0.930.640.421.241.08
Quick Ratio0.900.600.361.161.00
Efficiency Ratios
Asset Turnover1.121.250.970.750.73
Yield & Distribution Ratios
Earnings Yield0.04%0.03%0.04%0.02%0.03%
FCF Yield0.06%0.04%0.05%0.03%0.05%
Buyback Yield-0.01%0.05%0.11%0.00%0.00%